Picture of Shattuck Labs logo

STTK — Shattuck Labs News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Shattuck Labs Inc reports results for the quarter ended December 31 - Earnings Summary

Shattuck Labs Inc STTK.OQ reported a quarterly adjusted loss of 37 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -41 cents.  The mean expectation of five analysts for the quarter was for a loss of 32 cents per share. Wall Street expected results to range from -46 cents to -24 cents per share.

Reported revenue was zero​; analysts expected $799.40 thousand.

Shattuck Labs Inc's reported EPS for the quarter was a loss of 37 cents​.

The company reported a quarterly loss of $18.68 million.

Shattuck Labs Inc shares had fallen by 2.5% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 1.5% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Shattuck Labs Inc is $2.60

This summary was machine generated from LSEG data March 27 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Dec. 31 2024-0.32-0.37Missed
Sep. 30 2024-0.42-0.33Beat
Jun. 30 2024-0.41-0.42Missed
Mar. 31 2024-0.45-0.37Beat

Recent news on Shattuck Labs

See all news